Eighteen healthcare stocks now represent over a third of Investor’s Business Daily’s elite growth tracker, signaling a shift from tech.
Healthcare stocks accounted for 36% of the IBD 50 list of leading growth names as of July 2, up from recent periods. The tracker included 18 medical-related stocks, reflecting a broader market rotation away from technology sectors that had previously dominated the list.
The IBD 50, which highlights high-growth companies based on earnings, sales, and price performance, had seen tech stocks lead in prior weeks. The latest shift aligns with investor interest in defensive sectors amid economic uncertainty and sector-specific catalysts like drug approvals and healthcare innovation.
Eli Lilly (LLY) and other pharmaceutical firms featured prominently, while health insurer Alignment Healthcare (ALHC) recently broke out past a buy point, though analysts noted potential volatility.